Skip to content

Novel Markers for Detecting Early Progression of Glaucoma

Novel Markers for Detecting Early Progression of Glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03108443
Enrollment
250
Registered
2017-04-11
Start date
2018-04-01
Completion date
2026-05-31
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

Current methods of detecting glaucoma and monitoring its progression over time involve visual assessment of the optic nerve, thickness measurements of nerve tissue in the eye (using optical coherence tomography, OCT) as well as functional tests which measure peripheral, or side, vision. The objective of this study is to determine if a new technique of measuring blood flow in the eye, using OCT, can be used to better detect and/or monitor changes in glaucoma patients and suspects than these methods.

Detailed description

Changes in the superficial optic nerve head (ONH) surface and loss of retinal nerve fibre layer (RNFL) thickness detected with clinical imaging are predictive of future visual field loss. Imaging of the deep ONH, the likely origin of glaucomatous damage, represents the next logical next step, but has eluded clinicians because of the lack of capable technology. New advances in optical coherence tomography (OCT) imaging now offer an exciting opportunity to close the gap between the histomorphometric knowledge on deep ONH changes gained with research in experimental monkey glaucoma and imaging in clinical glaucoma. There is compelling evidence that gross ONH and retinal hemodynamic changes are functional indicators of glaucoma progression. Accurate tracking of blood flow in the ONH is a logical step, but has evaded researchers for several reasons including the highly reflective ONH tissue which variably inhibits signal penetration making the complex nature of retinal and posterior ciliary contributions to ONH flow difficult to segregate. Even though glaucoma damage originates in the ONH, retinal ganglion cell (RGC) axons may show the earliest functional alterations as they have high metabolic demand and vulnerability to damage. Therefore, tracking blood flow in the RNFL, which is highly segmental and resolvable, could be a better and more sensitive approach compared to that in the ONH. The macula contains almost 50% of the entire RGC population; likewise, monitoring blood flow in the macular inner vascular plexus corresponding to the ganglion cell layer (GCL) is likely to be highly informative for glaucoma progression. OCT based angiography (OCTA), which maps vessel density in different retinal vascular beds with unparalleled axial resolution, will finally allow us to quantify highly localized parameters related to blood flow and identify patients with higher progression risk. Current data analysis of progression detection based on inter-subject or population-based variability models are inefficient, leading to false-positive and false-negative results. Innovative data analysis techniques that build accurate models of intra-subject variability will add cumulative value to the novel imaging markers for progression.

Interventions

DIAGNOSTIC_TESTOptical Coherence tomography angiography

All subjects will have OCT angiography imaging performed

Sponsors

Balwantray Chauhan
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Glaucoma Group Inclusion Criteria: * visual acuity ≥ 6/12 * glaucomatous ONH change * glaucomatous visual field loss with a positive Glaucoma Hemifield Test

Exclusion criteria

* non-glaucomatous ocular disease * chronic systemic disease or treatment affecting the visual field * refraction exceeding 6 D equivalent sphere or 3 D astigmatism * inability to provide informed consent Control Group Inclusion Criteria: * visual acuity ≥ 6/12 * normal eye examination with intraocular pressure ≤ 21 mm Hg * normal visual field and negative Glaucoma Hemifield Test

Design outcomes

Primary

MeasureTime frameDescription
Blood flowChanges over the 5 year course of the studyEstablish whether blood flow changes occur and if there are differences in the groups.

Secondary

MeasureTime frameDescription
Optic nerve head (ONH) anatomyChanges over the 5 year course of the studyMeasure changes in the structure of the ONH

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026